Botulinum toxin in the treatment of sialorrhea [PDF]
Vojnosanitetski Pregled, 2009 Background/Aim. Botulinum toxin-A (BTX-A) is known to block the release of acetylcholine from motor and autonomic nerve terminals and may significantly decrease saliva production when injected intraglandulary.
Svetel Marina +5 more
doaj +6 more sources
The Sublingual Use of Atropine in the Treatment of Clozapine-Induced Sialorrhea: A Systematic Review
Clinical Case Reports (discontinued), 2019 Clozapine is considered the golden standard in the treatment of therapy‐resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea.
Thomas Van der Poorten, Marc De Hert
exaly +3 more sources
Feasibility and structure of a state hospital botulinum neurotoxin clinic for clozapine-induced sialorrhea [PDF]
Annals of General PsychiatryClozapine is uniquely effective for treatment-resistant schizophrenia, treatment-resistant mania, and for aggression, suicide, or psychogenic polydipsia related to schizophrenia.
Ai-Li W. Arias +3 more
doaj +3 more sources
Facial expression analysis to uncover the relationship between sialorrhea and hypomimia in Parkinson’s disease [PDF]
Frontiers in NeurologySialorrhea, or excessive drooling, is a prevalent yet frequently under-recognized non-motor symptom of Parkinson’s disease (PD). Hypomimia, or reduced facial expressivity, constitutes another significant feature of PD.
Eline Serbée +16 more
doaj +4 more sources
Sialorrhea with Neurological Diseases in Oral Medicine Fields: A Narrative Review [PDF]
Indonesian Journal of Dental Medicine, 2022 Background: Sialorrhea also known as drooling, literally means excessive saliva flow. In patients with neurological conditions such as Parkinson’s disease, cerebral palsy, and stroke. drooling or sialorrhea conditions can be a problem in their lives.
Diah Savitri Ernawati +1 more
doaj +3 more sources
Clinical Parkinsonism & Related Disorders, 2023 Sialorrhea, or drooling, is defined as excessive saliva accumulation and unwanted loss of saliva from the mouth or over the tongue and into the pharynx.
Bruno Bergmans +3 more
doaj +2 more sources
STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson’s disease [PDF]
npj Parkinson's Disease, 2022 The aims of this study were to assess the incidence rate and risk factors for sialorrhea in the long-term follow-up in a cohort of 132 patients with advanced Parkinson’s disease [88 with deep brain stimulation (DBS) and 44 on medical treatment].
Francesco Bove +8 more
doaj +2 more sources
The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea [PDF]
Turkish Archives of Otorhinolaryngology, 2018 Objective: The aim of this study was to evaluate the effect of Botulinum toxin type A by injecting in the submandibular and parotid glands on the frequency and severity of sialorrhea.Methods: Pediatric patients who were referred to our department with ...
Özgür Sürmelioğlu +6 more
doaj +3 more sources
Efficacy of transdermal scopolamine for sialorrhea in patients with amyotrophic lateral sclerosis [PDF]
Cogent Medicine, 2017 Background: Sialorrhea, the excessive flow of saliva from the mouth, causes distress in about half of patients with amyotrophic lateral sclerosis (ALS).
Kiyomi Odachi +7 more
doaj +3 more sources
Neurology and Therapy, 2020 Introduction Sialorrhea is a common and debilitating symptom associated with neurological conditions, which can result in considerable physical and psychosocial complications.
Koji Makino +3 more
doaj +2 more sources